NCT04774952 2025-04-15Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid TumorsRevolution Medicines, Inc.Phase 1 Completed58 enrolled
NCT04800822 2024-10-22PF-07284892 in Participants With Advanced Solid TumorsPfizerPhase 1 Terminated53 enrolled
NCT01470209 2018-03-19A Phase I Study of BKM120 and Everolimus in Advanced Solid MalignanciesEmory UniversityPhase 1 Completed43 enrolled